Precision Fermentation

Vivici Launches Vivitein™ LF Lactoferrin Ingredient in U.S. Market

Vivici raises €32.5 million ($33.7 million USD) in Series A funding to expand its precision fermentation dairy protein business.

Key Takeaways

  • Vivici launched Vivitein™ LF, a precision-fermented lactoferrin ingredient, in the U.S.
  • Ingredient aims to address historical supply and cost constraints associated with lactoferrin
  • Vivitein™ LF targets gut health, performance recovery, and iron utilization
  • Vivici secured self-affirmed GRAS status in the United States
  • Product expands Vivici’s Vivitein™ portfolio following Vivitein™ BLG

Vivici Introduces Precision-Fermented Lactoferrin

Dutch ingredients company Vivici has launched Vivitein™ LF in the U.S. market, introducing a precision-fermented lactoferrin ingredient designed to overcome traditional supply and cost limitations.

Lactoferrin, a whey protein often referred to as “pink gold,” has historically been difficult to scale due to its low natural abundance in milk. Vivici stated that Vivitein™ LF addresses these constraints by using precision fermentation to produce high-purity lactoferrin suitable for commercial application.

The ingredient is positioned for use in health and wellness products, particularly those focused on gut health, performance recovery, and sustained vitality.

administrator
As a dedicated journalist and entrepreneur, I helm iGrow News, a pioneering media platform focused on the evolving landscape of Agriculture Technology. With a deep-seated passion for uncovering the latest developments and trends within the agtech sector, my mission is to deliver insightful, unbiased news and analysis. Through iGrow News, I aim to empower industry professionals, enthusiasts, and the broader public with knowledge and understanding of technological advancements that shape modern agriculture. You can follow me on LinkedIn & Twitter.

Leave a Reply